CACHET PHARMACEUTICALS: Cachet’s strength lies in manufacturing quality medicines at affordable prices23 May 2018
CACHET PHARMACEUTICALS PVT. LTD. Is a leading Indian pharmaceutical company engaged in manufacturing and marketing of finished pharmaceutical and nutraceutical products globally.
The company has been rewarding with THE BIZZ Awards 2018 in the Inspirational Category in the ceremony in Prague.
We had an interview with Mr. Shashi Shekar Kumar, Vice-President of the company.
A brief description of the company:
Cachet Pharmaceuticals Pvt. Ltd is a leading Indian pharmaceutical company engaged in manufacturing and marketing of finished pharmaceutical and nutraceutical products globally.
Cachet is a subsidiary of Alkem Laboratories Ltd which ranks among the top 10 pharmaceutical companies in India.
Cachet has a formidable presence in over 30 countries covering 3 continents.
We make an effort to increase access to medicines to people of far-reaching areas as well as to reduce the burden of disease and improve the quality of life.
Cachet started as a contract manufacturer in 1978, with the first manufacturing facility commissioned in Rajasthan, India. The company started pharmaceutical marketing operations in 1992. Today Cachet is operating in the areas of Contract manufacturing, Indian operations of finished formulations and exports of finished formulations of pharmaceutical and nutraceutical products.
What are the goals of your company?
Providing quality healthcare at affordable prices.
To be recognized as a global healthcare provider with operations in more than 50 countries by the year 2020.
What are the competitive advantages of your company?
Cachet’s strength lies in manufacturing quality medicines at affordable prices. Cachet has three states of art manufacturing facilities run by qualified & expert professionals as per GMP guidelines. The first unit was set up in Rajasthan in the year 1987. We commissioned the second unit in 2006 at Himachal Pradesh. A new manufacturing facility has been commissioned at Sikkim this year. Cachet manufactures over 1 billion tablets and 260 million capsules every year in addition to liquid bottles and dry powders. Our Himachal Pradesh unit has several international accreditations such as WHO-GMP, TFDA-Tanzania, PPB-Kenya, NAFDAC-Nigeria, NDA-Uganda, DPM-Ivory Coast etc. The Sikkim unit focuses mainly on contract manufacturing and domestic business.
What has been achieved by your company since inception?
Cachet has grown exponentially in the last couple of decades. Starting as a contract manufacturer, the companies have now become a recognized player in the Indian pharmaceutical market. Several of our brands rank in top five as per ORG ranking. With a consistent focus on quality and customer satisfaction, we have achieved a respectable position in India and in several African countries including Kenya, Ethiopia, Uganda, Zambia and Francophone Africa. In recognition of our quality and services, we have received several accolades and awards from the industry.
- “International Star for Leadership in Quality Convention award” at Paris by Business Initiative Directions (BID)
- “European Award for Best practices 2016” at Brussels by European Society for Quality Research (ESQR)
- “UBM Initiative Recognition-Emerging Exporters of the Year 2016” for our business achievements by UBM India
However, our biggest achievement is our satisfied customer base.
What projects your company has developed?
Cachet has developed several brands which have achieved leadership positions, not only in India but also in the export markets. Traxol, Lysoflam, Cachnerve are just to name a few.
What are the most challenging goals that your company has accomplished?
The biggest challenge today is to remain competitive in the industry when the margins are shrinking and I think Cachet has done considerably well on this front.
Company Name: CACHET PHARMACEUTICALS PVT. LTD.
Company Representative: Mr. Shashi Shekar Kumar
The position of Company Representative: Vice-President